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1. Introduction 
The adenylate cyclase system (ATP pyrophosphate 
lyase (cyclizing) EC 4.6.1 .l) is a key factor in the 
action of many different hormones. This system is an 
intrinsic component of the cell membrane in euka- 
riotic cells, consisting at least of a receptor and of a 
catalytic unit; these are apparently connected within 
the membrane since binding of an effector to the 
receptor results in changes in the activity of the 
adenylate cyclase [l] . Little is known of the mecha- 
nism of the coupling process which occurs between 
the interaction of the hormone with the receptor 
and the stimulation of the enzyme itself. In particular, 
the existence of a specific component (‘transducer’) 
connecting the receptor and the catalytic unit remains 
hypothetical. Moreover, the exact role of guanine 
nucleotides in the modulation of this coupling process 
remains to be elucidated [2-41 . 
In the present study, we show that repeated wash- 
ing of a particulate fraction from rat liver (1000 X g 
pellet) resulted in an impairment in the response of 
adenylate cyclase to epinephrine. Functional coupling 
between the /3-adrenergic receptors and adenylate 
cyclase was restored upon addition of a cytosolic 
factor and GTP to the adenylate cyclase assay medium. 
These findings strongly argue for the existence of a 
specific transducing component, which may interact 
with guanine nucleotides, and which is responsible for 
the coupling of the hormone receptor with adenylate 
cyclase .
2. Materials and methods 
2.1. Materials 
Phentolamine, (+)alprenolol (Ciba Geity), (+)epi- 
nephrine (Sterling Winthrop), (+)propranolol (Imperial 
Chemical Industries) were obtained as gifts. (-)Epi- 
nephrine, (-)isoproterenol and nucleotides were from 
Sigma. Cyclic AMP and phosphocreatine were pur- 
chased from Calbiochem. Creatine phosphokinase was 
obtained from Boehringer. [~v~*P]ATP (6-29 Ci/ 
mmol) and (-)[3H]dihydroalprenolol (33 Ci/mmol) 
were obtained from the New England Nuclear Corp. 
and cyclic [8-3H]AMP (13 Ci/mmol) from the CEA 
(Saclay France). 
2.2. Preparation of rat liver fractions 
All steps were performed at 04°C. Livers from 
female, albino Wistar rats (about 100 g body wt) 
were homogenized in 5 vol. 1 mM NaHCOa with a 
Dounce homogenizer (loose pestle). The homogenate 
was filtered through 2 layers of cheesecloth and 
diluted twice after a sample was retained to serve as 
a source of homogenate. The particulate fraction 
refers to the pellet obtained after centrifugation at 
1000 X g for 15 min. This pellet was repeatedly 
washed by centrifugations at 1000 X g in 20 vol. 
1 mM NaHCOa, suspended in 2-3 vol. 1 mM NaHC03 
(so as to contain l-2.5 mg protein/ml) and finally 
homogenized in a Teflon-glass homogenizer. Fresh 
preparations were used for each experiment. 
For preparation of the 100 000 X g supernatant 
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fraction, minced livers were homogenized in a Dounce 
homogenizer in 1.5 vol. 1 mM NaHCOa. The filtered 
homogenate was subsequently centrifuged at 
100 000 X g for 1 h. The supernatant fraction, con- 
taining 30-45 mg protein/ml, was stored in liquid Na 
until use. No change in the activity was observed up 
to 3 months of storage. Several batches of frozen 
supernatant fractions gave similar results. 
2.3. Adenylate cyclase assay 
Adenylate cyclase activity was measured as reported 
[5,6] . Results are expressed in nmol cyclic AMP 
formed/IO min/mg protein at 30°C unless otherwise 
indicated. The results, obtained from triplicate deter- 
minations, agreed within 5%. 
2.4. Binding assay of (-)[ “Hjdihydroalprenolol 
The homogenate (2.5 mg protein/ml) or particulate 
fraction (l-2.5 mg protein/ml) was incubated at 30°C 
in an assay medium consisting of 50 mM Tris-HCl 
(pH 7.6) containing 10 mM MgClz (unless otherwise 
stated), and the indicated concentrations of (-)- 
[3H] dihydroalprenolol in final vol. 600 ~1. At the 
end of the incubation, four 100 ~1 aliquots were 
rapidly diluted with 4 ml cold 50 mM Tris-HCl 
(pH 7.6) containing 10 mM MgCla (wash buffer) and 
filtered through Whatman GF/F glass fiber under 
vacuum. The filters were washed twice with 4 ml cold 
wash buffer, placed in scintillation vials, eluted with 
1 ml methanol and finally counted by mixing with 
10 ml Unisolve (Koch-Light-Laboratory) in an Inter- 
technique SL 3 1 liquid scintillation counter. In each 
experiment, nonspecific binding was determined by 
measuring the amount of radioactivity retained on 
filters when incubations were performed in the pres- 
ence of 0.1 mM (+)alprenolol; such binding generally 
amounted to approx. 25% of the binding observed in 
incubations performed in the absence of (+)alprenolol. 
Similar results were obtained when only 5 PM (?) 
alprenolol was used instead of 0.1 mM. Specific bind- 
ing was defined as the total amount of (-)[3H]dihy- 
droalprenolol bound by the homogenate or by parti- 
culate fraction protein minus nonspecific binding. 
The results obtained from four determinations agreed 
within 10%. 
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3. Results 
3.1. Increase in adenylate cyclase activity and (-)- 
( 3H]dihydroalprenolol binding in washed parti- 
culate fractions 
Samples of the homogenate and 1000 X g pellet 
repeatedly washed in 1 mM NaHCOa were analyzed 
for adenylate cyclase activity and (-)[3H]dihydro- 
alprenolol binding (tig.1). Repeated washing resulted 
in progressive purification of basal adenylate cyclase 
activity and of alprenolol binding sites assayed at 
0.9 nM tritiated ligand; a 2.0-2.5-fold enrichment as 
compared to homogenate was observed after 4 washes. 
The use of (-)[3H]dihydroalprenolol as a specific 
marker of /3-adrenergic receptors has been substan- 
tiated in several systems [7] . Binding of this ligand 
to the liver particulate fraction reached equilibrium 
within 5 min and was saturable. Maximal binding 
corresponded to 0.32 pmol bound/mg protein at 3O”C, 
particulate (washing steps ) 
Fig.1. Basal adenylate cyclase activity and (-)I ‘Hldihydro- 
alprenolol binding in the homogenate and in the washed 
particulate fractions from rat liver. Assay conditions are 
described under Materials and methods. The protein con- 
tent per assay for binding and determination of adenylate 
cyclase activity was 1355 fig and 5 10 fig, respectively, when 
total liver homogenate was used (H). These values were 
1485-170 fig, 900-90 pug, 550-60 fig, 860-60 ug, 1050-80 c1g 
when particulate fractions washed 0, 1, 2, 3,4 times, respec- 
tively, were used. Adenylate cyclase activity is expressed in 
pmol cyclic AMP formed/l0 min/mg protein and is repre- 
sented by the hatched bars. The specific binding (-)[ ‘H] dihy- 
droalprenolol, represented by the open bars, is expressed 
in fmol bound/mg protein after 15 min incubation at 0.9 nM 
(-)[ 3H]dihydroalprenolol (13 000 cpm). The results are the 
mean k SE of four determinations in fractions from two 
animals. 
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pH 7.6. As determined by Scatchard analysis, (-)- 
[3H]dihydroalprenolo1 interacted with a single class 
of non-cooperative binding sites with an apparent 
dissociation constant (Kd) 9.0 nM. Kinetic analysis 
gave a first-order rate constant for the dissociation 
k2 0.37 min-’ and a second-order ate constant kl for 
the association 28 . lo6 M-’ min-‘. The ratio kz/kl = 
13.2 nM confirmed the value of K, obtained by 
Scatchard analysis. Displacement of (-)[3H]dihydro- 
alprenolol from membrane binding sites permitted 
estimation of the K, values of various other drugs. 
They clearly indicate that (-) [jH] dihydroalprenolol 
binds to the physiological /.Cadrenergic receptors of 
rat liver. Adrenergic /3 agonists competed for the 
binding sites with the following order of potencies: 
(-)isoproterenol (Kd 4.5 nM) > (-)epinephrine 
(Kd 450 nM) > (+) epinephrine (Kd 4500 nM). 
Adrenergic p antagonists such as (+) propranolol and 
(t) alprenolol were strong competitors with 1y, 
90 nM and 9 nM respectively, whereas the 01 antagonist, 
phentolamine, had only a weak affinity for the bind- 
ing sites (I& 27 PM). 
3.2. Effect of washing on the catecholamine-sensitive 
adenylate cyclase 
Repeated washing of the particulate fraction 
rendered the adenylate cyclase unresponsive to epi- 
nephrine (tig.2.): a 50% reduction in the stimulation of 
the adenylate cyclase by epinephrine occurred after 
the first centrifugation step. After 4 washes, the parti- 
culate fraction exhibited a very low and non-repro- 
ducible sensitivity to epinephrine. 
3.3. Reversal of the effect of washing by addition of 
100 000 X g supematant and GTP 
The reduction in the stimulation of adenylate 
cyclase activity by epinephrine which occurred after 
repeated washing could not be correlated with either 
a loss of adenylate cyclase itself or a depletion of the 
/3-adrenergic receptors: this is clearly shown by the 
results depicted in fig.1. We therefore considered the 
possibility that the change in the properties of the 
adenylate cyclase could be due to the loss of soluble 
factors. The epinephrine sensitivity of the washed par- 
ticulate fraction was examined as a function of 
increasing amounts of 100 000 X g supernatant pro- 
tein, or of GTP, or of both added together to the 
incubation medium (fig.3). Addition of supernatant 
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Fig.2. Catecholamine-sensitive adenylate cyclase in homo- 
genate and in washed particulate fractions from rat liver. 
Adenylate cyclase from homogenate (H) and from particulate 
fractions washed repeatedly was measured in the presence and 
absence of 50 PM epinephrine in the assay medium described 
under Materials and methods. The protein content per assay 
is reported in the legend to fig.1. The results are expressed as 
percent activition over basal activity represented in fig.1 and 
are the mean of four determinations. 
1. 
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Fig.3. The effect of increasing concentrations of GTP and of 
the 100 000 X g supernatant on epinephrine responsiveness. 
The adenylate cyclase activity in a particulate fraction washed 
four times (69 gg protein/assay) was measured as described 
under Materials and methods, in the presence of varying 
amounts of cytosol protein (o), or GTP (A), added separaiely 
or together (o) to the assay medium. The experiment was 
performed in the presence and absence of 50 PM epinephrine. 
Adenylate cyclase activity is expressed as percent activation 
due to epinephrine over basal level. The results are the mean 
of triplicate determinations; the experiment was repeated 
three times. 
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alone resulted in a 4-fold increase in the basal adenyl- 
ate cyclase activity (not shown) but did not reveal 
any sensitivity to epinephrine. In the presence of GTP, 
a 4-fold increase in the basal level was also obtained, 
and was accompanied with a weak response to epi- 
nephrine at 100 PM GTP (16% activation over basal 
level). Finally, addition of both supernatant and 
GTP restored the response to epinephrine: stimula- 
tion of the adenylate cyclase from the washed parti- 
culate fraction by 50 PM epinephrine was readily 
detectable at 1 ,ug supernatant protein plus 0.1 /.IM 
GTP; addition of maximally effective concentrations 
of both effecters (20 pg supernatant protein, 0.1 mM 
GTP) resulted in a 45% activation of epinephrine over 
basal activity. This restored sensitivity to epinephrine 
was confirmed when adenylate cyclase activity was 
tested as a function of hormone concentration (fig.4). 
Epinephrine had no effect upon cyclase in the absence 
of effecters; in contrast, in the presence of 20 pg 
supernatant protein and 0.1 mM GTP, epinephrine 
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Fig.4. Effect of 100 000 X g supernatant plus GTP on epi- 
nephrine sensitivity of adenylate cyclase from washed particulate 
fraction. The adenylate cyclase activity in a particulate frac- 
tion washed four times (21 r.~g protein/assay) was measured 
in the assay medium described under Materials and methods 
in the presence of varying concentrations of epinephrine and 
in the absence (0) or presence (0) of 20 fig cytosol protein 
plus 0.1 mM GTP. Adenylate cyclase activity is expressed as 
nmol cyclic AMP formed/l0 min/mg protein. The data are 
the mean of triplicate determinations; the experiment was 
repeated three times. 
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activated the particulate adenylate cyclase over the 
concentration range 0.1-100 PM, producing half- 
maximal activation at 2 ,uM. Similar values were 
obtained under other experimental conditions using 
membranes from adrenalectomized rats [5] or using 
non-washed particulate fractions in the presence of 
GTP [8] . This effect of epinephrine was abolished 
by 0.1 E.IM (+)propranolol (data not shown). 
3.4. Lack of effect of GTP and 100 000 X g super- 
natant on epinephrine binding 
Competition experiments of epinephrine for 
(-)[3H]dihydroalprenolol binding sites were per- 
formed in the presence and absence of 100 000 X g 
supernatant protein and GTP at concentrations maxi- 
mally effective in promoting resensitization of 
adenylate cyclase to epinephrine. These experiments 
were performed’in the medium used for adenylate 
cyclase assay: thus, the assay conditions for both 
experiments reported in figs.4. and 5 were identical. 
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Fig.5. Lack of effect of 100 000 X g supernatant plus GTP on 
competition of epinephrine for (-) [ ‘H] dihydroalprenolol 
binding sites in the washed particulate fraction. (-)[3H]dihy- 
droalprenolol (13 000 cpm) at a concentration of 0.9 nM 
was incubated with particulate fraction washed four times 
(1.5 mg protein/ml) for 15 min at 30°C in the medium for 
adenylate cyclase assay, in the presence of increasing concen- 
trations of epinephrine. The experiment was performed in the 
absence (0) or in the presence of 20 fig supernatant protein 
plus 0.1 mM GTP (0). The results are expressed as percent 
of maximal binding (20 fmol (-)[sH]dihydroalprenolol 
bound/mg protein under both experimental conditions) and 
are the mean of four determinations from two experiments. 
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Cytosol plus GTP did not affect the amount of 
(-)[3H]dihydroalprenolol bound in the absence of 
cold l&and; the displacement curve by epinephrine 
was unchanged (fig.5 .). 
4. Discussion 
Direct evidence to demonstrate that the P-adrener- 
gic receptor and the catalytic unit of the adenylate 
cyclase are two separable macromolecules has 
recently been provided [9,10] . The remaining ques- 
tion concerns the mechanism of the coupling pro- 
cess which occurs following hormone-receptor inter- 
action and which results in stimulation of adenylate 
cyclase. In fact, the available experimental data 
strongly argue for the existence of a component 
modulating the efficacy of receptor-enzyme coupling. 
Thus, in rat kidney medulla, it was suggested that 
adrenal steroids were implicated in the control of 
synthesis of such a coupling component [ 1 l] . Uncou- 
pling of the catecholamine activation of adenylate 
cyclase was also observed in pigeon erythrocyte mem- 
branes treated with filipin with no modification 
neither in hormone binding to the receptor nor in the 
activity of the catalytic unit of the adenylate cyclase 
system [ 12,131 .The observation by Haga et al. [ 141 
that a mutant clone of S 49 mouse lymphoma cell 
line retained /I-adrenergic receptors but lacked 
hormone-responsive adenylate cyclase activity further 
supports the suggestion that components distinct 
from hormone receptor and catalytic unit, regulate the 
hormone responsiveness of the cyclase. 
Guanine nucleotides are well known to stimulate 
adenylate cyclase activity and to alter hormone bind- 
ing [2,5 ,151; this role has been strengthened by the 
description of binding sites for these nucleotides 
associated with adenylate cyclase in various tissues 
[ 16,201. Thus it is generally accepted, but not demon- 
strated, that guanine nucleotides are involved in the 
coupling mechanism. A further indication that this 
indeed might occur is the observation that desensitiza- 
tion of /3-adrenergic receptors by fl-adrenergic agonists 
could be reversed by guanine nucleotides in frog 
erythrocyte membranes [21]. As a working hypothesis, 
it can be admitted that the various hormone receptors 
would have a common attachment site by which they 
couple to the nucleotide binding unit [9] . 
It is well known that adenylate cyclase from puri- 
fied plasma membranes of normal rat liver is not sen- 
sitive to epinephrine in vitro [22-251 unless either 
GTP [26] or a cytosolic protein-nucleotide factor [6] 
are added to the assay mixture. In the light of the data 
reported here, it is clear that this unresponsiveness 
is due to the loss of a coupling factor during the 
purification procedure. Repeated washing in 1 mM 
NaHCOs of a crude particulate fraction from rat liver 
results in a loss of sensitivity of the adenylate cyclase 
to epinephrine. This occurs independently of any 
impairment in binding capacity and in adenylate 
cyclase activity which were even increased after 
repeated washing (figs 1. and 2.). The coupling process 
is restored by a cytosolic factor interacting with GTP 
in vitro. It is tempting to assume that the coupling 
factor lost during the washing at low ionic strength, 
is the GTP protein factor described [6] . We suggest 
that GTP protein complex present in the cytosol, 
might easily recombine with the uncoupled receptor 
and catalytic unit of the adenylate cyclase. 
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